AtriCure Q3 2026 Results: Turns Profitable, Net Income $4.06M
AtriCure, Inc. reported a significant turnaround for the nine months ended September 30, 2026, achieving a net income of $13.1 million compared to a net loss of $13.2 million in the prior year period. Revenue grew 14% year-over-year to $449.3 million, driven by strong performance in surgical treatments for atrial fibrillation and left atrial appendage management.
- Key figure
- Net income $4.06M